[{"Assets_0_Q1_USD":5613561.0,"CommonStockSharesOutstanding_0_Q1_shares":12545120.0,"NetIncomeLoss_1_Q1_USD":-981686.0,"StockholdersEquity_0_Q1_USD":1464662.0,"Ticker":"RLMD","CIK":"1553643","name":"RELMADA THERAPEUTICS, INC.","OfficialName":"Relmada Therapeutics Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"772606380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171114"}]